3/18
06:49 am
gild
3 Reasons to Avoid GILD and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Avoid GILD and 1 Stock to Buy Instead [Yahoo! Finance]
3/17
09:00 am
gild
Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast Cancer
Low
Report
Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast Cancer
3/17
06:28 am
gild
3 Cash-Flow Machines Investors May Want Heading Into 2026 [Yahoo! Finance]
Low
Report
3 Cash-Flow Machines Investors May Want Heading Into 2026 [Yahoo! Finance]
3/17
05:48 am
gild
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth [Yahoo! Finance]
Low
Report
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth [Yahoo! Finance]
3/15
05:59 pm
gild
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades [Yahoo! Finance]
Low
Report
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades [Yahoo! Finance]
3/13
11:38 am
gild
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise? [Yahoo! Finance]
Low
Report
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise? [Yahoo! Finance]
3/12
09:11 am
gild
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy [Yahoo! Finance]
Low
Report
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy [Yahoo! Finance]
3/10
09:00 am
gild
Gilead Sciences (GILD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $180.00 price target on the stock.
Low
Report
Gilead Sciences (GILD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $180.00 price target on the stock.
3/8
11:10 pm
gild
???????????????????? :???????????????2035????2388?2000????????????????????(CAGR)6.0%???????????? [CNET News]
Low
Report
???????????????????? :???????????????2035????2388?2000????????????????????(CAGR)6.0%???????????? [CNET News]
3/7
07:03 pm
gild
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run [Yahoo! Finance]
Low
Report
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run [Yahoo! Finance]
3/7
05:21 pm
gild
Gilead's BIC LEN HIV Results Highlight Valuation Gap And Future Potential [Yahoo! Finance]
Low
Report
Gilead's BIC LEN HIV Results Highlight Valuation Gap And Future Potential [Yahoo! Finance]
3/6
11:06 am
gild
Gilead Sciences (GILD) had its "buy" rating reaffirmed by Citigroup Inc..
Low
Report
Gilead Sciences (GILD) had its "buy" rating reaffirmed by Citigroup Inc..
3/4
08:19 am
gild
Gilead Sciences (GILD) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
Low
Report
Gilead Sciences (GILD) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
3/3
08:42 pm
gild
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance [Yahoo! Finance]
Low
Report
Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance [Yahoo! Finance]
3/2
08:55 am
gild
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia [Yahoo! Finance]
Low
Report
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia [Yahoo! Finance]
3/2
08:30 am
gild
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
Low
Report
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
3/2
08:01 am
gild
3T Biosciences Appoints Rebeca Villarreal-Barragan, MBA, as Head of Clinical Operations [Yahoo! Finance]
Low
Report
3T Biosciences Appoints Rebeca Villarreal-Barragan, MBA, as Head of Clinical Operations [Yahoo! Finance]
2/28
01:40 pm
gild
Assessing Gilead Sciences (GILD) Valuation As Recent Share Price Momentum Meets Conflicting Fair Value Signals [Yahoo! Finance]
Low
Report
Assessing Gilead Sciences (GILD) Valuation As Recent Share Price Momentum Meets Conflicting Fair Value Signals [Yahoo! Finance]
2/27
12:12 pm
gild
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector? [Yahoo! Finance]
Low
Report
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector? [Yahoo! Finance]
2/26
09:21 am
gild
Gilead Sciences (GILD) had its price target raised by Daiwa Securities Group Inc. from $129.00 to $161.00. They now have an "outperform" rating on the stock.
Low
Report
Gilead Sciences (GILD) had its price target raised by Daiwa Securities Group Inc. from $129.00 to $161.00. They now have an "outperform" rating on the stock.
2/26
08:34 am
gild
CNBC Changemakers and Power Players Podcast: Gilead Sciences Chief Commercial & Corporate Affairs Officer and 2026 CNBC Changemaker Johanna Mercier on ending HIV epidemic, life hacks, and her leadership superpower [CNBC]
Low
Report
CNBC Changemakers and Power Players Podcast: Gilead Sciences Chief Commercial & Corporate Affairs Officer and 2026 CNBC Changemaker Johanna Mercier on ending HIV epidemic, life hacks, and her leadership superpower [CNBC]
2/25
01:54 pm
gild
Gilead's Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy [Yahoo! Finance]
Low
Report
Gilead's Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy [Yahoo! Finance]
2/25
01:44 pm
gild
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
Low
Report
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
2/25
07:18 am
gild
2 Nasdaq 100 Stocks Worth Your Attention and 1 We Question [Yahoo! Finance]
Low
Report
2 Nasdaq 100 Stocks Worth Your Attention and 1 We Question [Yahoo! Finance]
2/24
03:16 pm
gild
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion [Yahoo! Finance]
Low
Report
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion [Yahoo! Finance]